IDI1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	31 studies	29% ± 8%	Explore
natural killer cell	31 studies	29% ± 9%	Explore
CD8-positive, alpha-beta T cell	23 studies	24% ± 7%	Explore
CD4-positive, alpha-beta T cell	20 studies	24% ± 7%	Explore
T cell	17 studies	27% ± 8%	Explore
endothelial cell	17 studies	26% ± 7%	Explore
regulatory T cell	17 studies	27% ± 6%	Explore
mast cell	16 studies	27% ± 9%	Explore
naive B cell	16 studies	26% ± 7%	Explore
mature NK T cell	16 studies	26% ± 8%	Explore
memory B cell	16 studies	28% ± 10%	Explore
gamma-delta T cell	14 studies	30% ± 12%	Explore
CD16-positive, CD56-dim natural killer cell, human	13 studies	31% ± 9%	Explore
fibroblast	13 studies	23% ± 8%	Explore
macrophage	12 studies	22% ± 7%	Explore
CD16-negative, CD56-bright natural killer cell, human	12 studies	27% ± 8%	Explore
astrocyte	12 studies	31% ± 17%	Explore
epithelial cell	10 studies	32% ± 18%	Explore
mucosal invariant T cell	10 studies	23% ± 10%	Explore
basal cell	10 studies	24% ± 9%	Explore
ciliated cell	10 studies	26% ± 10%	Explore
type II pneumocyte	9 studies	33% ± 14%	Explore
smooth muscle cell	9 studies	20% ± 3%	Explore
CD8-positive, alpha-beta memory T cell	9 studies	28% ± 9%	Explore
classical monocyte	8 studies	25% ± 10%	Explore
non-classical monocyte	8 studies	28% ± 13%	Explore
endothelial cell of vascular tree	8 studies	21% ± 4%	Explore
CD4-positive, alpha-beta memory T cell	8 studies	27% ± 8%	Explore
conventional dendritic cell	7 studies	28% ± 17%	Explore
connective tissue cell	7 studies	20% ± 5%	Explore
plasmacytoid dendritic cell	7 studies	25% ± 11%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	26% ± 7%	Explore
effector memory CD8-positive, alpha-beta T cell	6 studies	32% ± 12%	Explore
neuron	6 studies	25% ± 10%	Explore
pericyte	6 studies	23% ± 5%	Explore
GABAergic neuron	6 studies	31% ± 14%	Explore
goblet cell	6 studies	28% ± 7%	Explore
monocyte	5 studies	31% ± 11%	Explore
ionocyte	5 studies	26% ± 7%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	26% ± 7%	Explore
leukocyte	5 studies	31% ± 8%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	23% ± 5%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	5 studies	27% ± 4%	Explore
progenitor cell	5 studies	18% ± 2%	Explore
amacrine cell	5 studies	42% ± 15%	Explore
retinal ganglion cell	5 studies	72% ± 29%	Explore
precursor B cell	5 studies	33% ± 8%	Explore
pro-B cell	5 studies	26% ± 4%	Explore
oligodendrocyte	5 studies	23% ± 3%	Explore
T follicular helper cell	5 studies	32% ± 13%	Explore
innate lymphoid cell	5 studies	27% ± 6%	Explore
abnormal cell	5 studies	21% ± 6%	Explore
dendritic cell	4 studies	35% ± 17%	Explore
type B pancreatic cell	4 studies	31% ± 12%	Explore
exhausted T cell	4 studies	28% ± 8%	Explore
immature B cell	4 studies	31% ± 6%	Explore
retinal pigment epithelial cell	4 studies	48% ± 19%	Explore
Mueller cell	4 studies	38% ± 7%	Explore
secretory cell	4 studies	26% ± 8%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	32% ± 8%	Explore
granulocyte	4 studies	35% ± 12%	Explore
glutamatergic neuron	4 studies	45% ± 19%	Explore
oligodendrocyte precursor cell	4 studies	40% ± 18%	Explore
T-helper 17 cell	4 studies	29% ± 11%	Explore
type I pneumocyte	3 studies	26% ± 10%	Explore
squamous epithelial cell	3 studies	38% ± 20%	Explore
mononuclear phagocyte	3 studies	25% ± 8%	Explore
hematopoietic precursor cell	3 studies	35% ± 14%	Explore
glomerular endothelial cell	3 studies	20% ± 4%	Explore
kidney loop of Henle epithelial cell	3 studies	21% ± 4%	Explore
retinal bipolar neuron	3 studies	30% ± 9%	Explore
OFF-bipolar cell	3 studies	48% ± 33%	Explore
GABAergic amacrine cell	3 studies	34% ± 14%	Explore
glycinergic amacrine cell	3 studies	30% ± 13%	Explore
myeloid cell	3 studies	35% ± 9%	Explore
retina horizontal cell	3 studies	29% ± 6%	Explore
retinal cone cell	3 studies	34% ± 3%	Explore
retinal rod cell	3 studies	23% ± 3%	Explore
germinal center B cell	3 studies	21% ± 1%	Explore
pancreatic A cell	3 studies	49% ± 11%	Explore
pancreatic ductal cell	3 studies	46% ± 9%	Explore
club cell	3 studies	25% ± 2%	Explore
group 3 innate lymphoid cell	3 studies	30% ± 13%	Explore
hepatocyte	3 studies	45% ± 35%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	10 studies	24% ± 6%	Explore
peripheral blood	10 studies	27% ± 14%	Explore
eye	8 studies	29% ± 7%	Explore
brain	7 studies	29% ± 14%	Explore
intestine	6 studies	20% ± 5%	Explore
liver	5 studies	25% ± 8%	Explore
pancreas	4 studies	34% ± 15%	Explore
breast	4 studies	21% ± 5%	Explore
bone marrow	3 studies	24% ± 7%	Explore
uterus	3 studies	26% ± 10%	Explore
adrenal gland	3 studies	23% ± 4%	Explore
kidney	3 studies	18% ± 2%	Explore
lymph node	3 studies	26% ± 12%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
prostate	100%	2980.71	245 / 245	100%	57.71	501 / 502
brain	100%	4827.16	2636 / 2642	100%	69.98	705 / 705
liver	100%	6348.01	226 / 226	100%	84.84	405 / 406
esophagus	100%	2815.96	1439 / 1445	100%	42.58	183 / 183
stomach	100%	3011.83	359 / 359	99%	43.91	284 / 286
intestine	100%	2990.69	966 / 966	99%	51.28	523 / 527
breast	100%	2645.98	459 / 459	99%	52.66	1109 / 1118
lung	99%	4732.44	575 / 578	99%	45.57	1149 / 1155
uterus	99%	1886.81	169 / 170	99%	43.22	455 / 459
adrenal gland	100%	8909.83	258 / 258	98%	103.08	226 / 230
bladder	100%	2087.38	21 / 21	97%	44.05	490 / 504
thymus	99%	2217.55	649 / 653	97%	23.55	584 / 605
ovary	98%	2785.49	176 / 180	96%	26.36	414 / 430
skin	100%	3210.28	1802 / 1809	92%	35.48	432 / 472
pancreas	90%	1339.09	295 / 328	99%	37.75	176 / 178
kidney	100%	2805.16	89 / 89	87%	18.39	788 / 901
lymph node	0%	0	0 / 0	100%	54.52	29 / 29
muscle	100%	6656.33	803 / 803	0%	0	0 / 0
spleen	100%	5094.39	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	41.02	45 / 45
ureter	0%	0	0 / 0	100%	15.13	1 / 1
adipose	100%	3008.23	1203 / 1204	0%	0	0 / 0
blood vessel	99%	2279.87	1325 / 1335	0%	0	0 / 0
peripheral blood	92%	5081.84	851 / 929	0%	0	0 / 0
heart	88%	1570.98	761 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	64%	14.17	51 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006695	Biological process	cholesterol biosynthetic process
GO_0050992	Biological process	dimethylallyl diphosphate biosynthetic process
GO_0009240	Biological process	isopentenyl diphosphate biosynthetic process
GO_0005829	Cellular component	cytosol
GO_0005777	Cellular component	peroxisome
GO_0005737	Cellular component	cytoplasm
GO_0004452	Molecular function	isopentenyl-diphosphate delta-isomerase activity
GO_0046872	Molecular function	metal ion binding

IV. Literature review

[source]

Gene name	IDI1
Protein name	Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1) Isopentenyl-diphosphate delta isomerase 1
Synonyms	hCG_24699
Description	FUNCTION: Catalyzes the 1,3-allylic rearrangement of the homoallylic substrate isopentenyl (IPP) to its highly electrophilic allylic isomer, dimethylallyl diphosphate (DMAPP). . FUNCTION: Catalyzes the 1,3-allylic rearrangement of the homoallylic substrate isopentenyl (IPP) to its highly electrophilic allylic isomer, dimethylallyl diphosphate (DMAPP). .
Accessions	C9JD53 ENST00000427898.5 ENST00000429642.2 [Q13907-1] ENST00000381344.8 [Q13907-2] Q13907 ENST00000695775.1 A0A8Q3WKR8

IDI1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review